US regulators have lifted restrictions on the use of the coronavirus vaccine by the American company Johnson & Johnson. This is reported by The New York Times.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) agreed that the use of the vaccine is worth continuing, and the drug itself is safe and effective. A warning about the potential risk of blood clots will be added to the label.
Ten experts voted for the resumption of the use of the vaccine in the United States, four were against it. According to the new recommendation, the drug can be used for all US residents over the age of 18.
At the same time, women under 50 years of age should be warned about very rare side effects in the form of blood clots. It is expected that they will be given the opportunity to choose other vaccines approved for use in the United States.
Earlier in April, US regulators wanted to ban the use of the Johnson & Johnson vaccine due to blood clots in vaccinated patients. The Food and Drug Administration (FDA) reported that more than 6.8 million doses of the drug were administered in the United States, with six cases of severe thrombosis in vaccinated patients.